Workflow
24/7 Market News: Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs
Globenewswire· 2025-09-30 12:45
DENVER, Sept. 30, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, highlights the opportunity for recombinant spider silk produced by Kraig Biocraft Laboratories (OTCQB: KBLB), the global leader in the development and commercialization of spider silk. 24/7 Market News believes that some of the most obvious projected use-cases include compression gear, perspiration-wicking layers, temperature-regulating base l ...
ADT Announces $1.0 Billion Notes Offering
Globenewswire· 2025-09-30 12:44
BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), today announced that its indirect wholly owned subsidiary, The ADT Security Corporation, is proposing to issue and sell $1.0 billion aggregate principal amount of first-priority senior secured notes due 2033 (the “Notes”) in an offering that will be exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”) (the “Offering”). The Company intends to use the procee ...
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
Globenewswire· 2025-09-30 12:40
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutations Company Reports first evidence of gastric cancer activity expands potential therapeutic reach of SIL204 GRAND CAYMAN, Cayman Islands, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven ...
Transocean Ltd. Announces Proposed Private Offering of Senior Priority Guaranteed Notes Due 2032
Globenewswire· 2025-09-30 12:32
STEINHAUSEN, Switzerland, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today that Transocean International Limited, a Bermuda exempted company limited by shares and a wholly owned subsidiary of Transocean Ltd. (the “Company” and, together with Transocean Ltd., “Transocean”), commenced a private offering of $500 million aggregate principal amount of Senior Priority Guaranteed Notes due 2032 (the “Notes”) to eligible purchasers pursuant to Rule 144A/Regulation S (the “Notes Offerin ...
Barnes & Noble College Launches Campus to Career, a NEW Offering to Help Students Build Real-World Skills to Enter the Workforce
Globenewswire· 2025-09-30 12:31
BASKING RIDGE, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Barnes & Noble College (BNC), a Barnes & Noble Education, Inc. (NYSE: BNED) company and leading solutions provider for higher education, today announced the launch of Campus to Career — a new offering designed to equip college students with the tools, resources and insights they need to help transition from the classroom to the workplace. Campus to Career offers a curated collection of products available both in-store and online, along with an exclusiv ...
Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia
Globenewswire· 2025-09-30 12:30
BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that it has been invited to attend the J.P. Morgan Asset Management, Life Science Innovation Forum (LSIF) 2025 in Collaboration with KAIMRC, taking place October 1–2, 2025, at the King Saud bin Abdulaz ...
24/7 Market News: Analyst Upgrades amongst Flurry of Moves Venu Holdings Coverage
Globenewswire· 2025-09-30 12:30
Sees Emergence of a New Real Estate Asset ClassDENVER, Sept. 30, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that ThinkEquity upgraded VENU (NYSE American: VENU), a growing operator of premium hospitality and live entertainment venues across the U.S., in a comprehensive investment report titled “Venu Holdings: Forging a New Asset Class in Experiential Real Estate.” The firm issued a Buy ...
Amaze Hosts Breakaway Music Festival’s Creator Lab Official Merchandise Store
Globenewswire· 2025-09-30 12:30
Amaze Powers Merchandise Design Contest and Seamless Shopping Experience for FansNEWPORT BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”), a global leader in creator-powered commerce, today announced its collaboration with Breakaway Music Festival. Through this partnership, Amaze will power the Breakaway Music Festival official merchandise store and launch the Breakaway Creator Lab, a design competition inviting artists to submit original merchandise con ...
September 2025 Letter to Shareholders
Globenewswire· 2025-09-30 12:30
VANCOUVER, Washington, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As this pivotal year continues to take shape for CytoDyn Inc. (“CytoDyn” or the “Company”), I am pleased to share the progress we have made in advancing leronlimab as an innovative treatment in oncology. We remain confident that addressing critical unmet needs in this field is the best way to build value while improving the lives of patients. The foundation of our conviction in leronlimab rests on both preclinical and clinical evi ...
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access
Globenewswire· 2025-09-30 12:30
Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, the first new fibromyalgia therapy in more than 15 years US Launch of Tonmya expected in the fourth quarter of 2025 CHATHAM, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Compan ...